Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio
recent articles
Indica Labs, a leading provider of computational pathology software and services, is looking forward to attending AACR 2023, and we hope to see you at our booth #710 in Orlando, April 14-19! Our Applications Scientists will be available to...
SPOKANE, Wash. and SALT LAKE CITY, April 12, 2023 /PRNewswire/ -- Gestalt Diagnostics Inc., a leading provider of Artificial Intelligence (AI)-powered digital pathology solutions, and ARUP Laboratories, a national academic reference...
PathAI: Latest research underscores advantages of digital tools at scale to enhance tumor microenvironment and biomarker understanding in non-small cell lung cancer and renal cell carcinoma BOSTON, Mass., April 11, 2023 /PRNewswire/...
Houston is one of seven global Precision specialty labs addressing the rising demand for rapid, comprehensive biomarker data to support the development of advanced therapies and diagnostics HOUSTON, April 11, 2023 /PRNewswire/ -- Precision...
Invitation from Deep Bio: Our team is ready to greet you at booth #3445! Find out how DeepDx® Prostate empowers pathologists. Also, Deep Bio will present two research abstracts in relation to biomarker in prostate and breast cancers at...
PathAI PathExplore™ panel will empower oncology drug developers with improved tumor microenvironment spatial characterization from H&E, propelling a new phase of precision medicine. BOSTON, April 4, 2023 /PRNewswire/ -- PathAI, a...
